nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS2—Thalidomide—leprosy	0.158	0.183	CbGbCtD
Meloxicam—PTGS1—Thalidomide—leprosy	0.134	0.154	CbGbCtD
Meloxicam—PTGS2—Dapsone—leprosy	0.126	0.146	CbGbCtD
Meloxicam—PTGS1—Dapsone—leprosy	0.107	0.123	CbGbCtD
Meloxicam—CYP2C8—Rifampicin—leprosy	0.0746	0.0863	CbGbCtD
Meloxicam—CYP2C8—Dapsone—leprosy	0.0616	0.0712	CbGbCtD
Meloxicam—CYP2C9—Thalidomide—leprosy	0.0537	0.0621	CbGbCtD
Meloxicam—CYP2C9—Rifampicin—leprosy	0.0521	0.0602	CbGbCtD
Meloxicam—CYP2C9—Dapsone—leprosy	0.043	0.0497	CbGbCtD
Meloxicam—CYP3A4—Rifampicin—leprosy	0.0303	0.035	CbGbCtD
Meloxicam—CYP3A4—Dapsone—leprosy	0.025	0.0289	CbGbCtD
Meloxicam—Inner ear disorder—Thalidomide—leprosy	0.00905	0.0691	CcSEcCtD
Meloxicam—Labyrinthine disorder—Thalidomide—leprosy	0.00905	0.0691	CcSEcCtD
Meloxicam—Gastrointestinal perforation—Thalidomide—leprosy	0.00435	0.0332	CcSEcCtD
Meloxicam—Albuminuria—Dapsone—leprosy	0.00297	0.0227	CcSEcCtD
Meloxicam—Meningitis—Thalidomide—leprosy	0.00293	0.0224	CcSEcCtD
Meloxicam—Intestinal perforation—Thalidomide—leprosy	0.00287	0.0219	CcSEcCtD
Meloxicam—Gastric ulcer—Thalidomide—leprosy	0.00195	0.0149	CcSEcCtD
Meloxicam—Serum creatinine increased—Thalidomide—leprosy	0.00185	0.0141	CcSEcCtD
Meloxicam—Albuminuria—Thalidomide—leprosy	0.00152	0.0116	CcSEcCtD
Meloxicam—Nasopharyngitis—Dapsone—leprosy	0.00144	0.011	CcSEcCtD
Meloxicam—Influenza—Dapsone—leprosy	0.00139	0.0106	CcSEcCtD
Meloxicam—Pancreatitis—Dapsone—leprosy	0.00136	0.0104	CcSEcCtD
Meloxicam—Photosensitivity reaction—Dapsone—leprosy	0.00127	0.0097	CcSEcCtD
Meloxicam—Hyperbilirubinaemia—Thalidomide—leprosy	0.00125	0.00953	CcSEcCtD
Meloxicam—Drug interaction—Thalidomide—leprosy	0.00122	0.00934	CcSEcCtD
Meloxicam—Creatinine increased—Thalidomide—leprosy	0.00119	0.0091	CcSEcCtD
Meloxicam—Sinusitis—Dapsone—leprosy	0.00116	0.00889	CcSEcCtD
Meloxicam—Eructation—Thalidomide—leprosy	0.00112	0.00852	CcSEcCtD
Meloxicam—Pharyngitis—Dapsone—leprosy	0.00111	0.00844	CcSEcCtD
Meloxicam—Colitis—Thalidomide—leprosy	0.00109	0.00832	CcSEcCtD
Meloxicam—Blood urea increased—Thalidomide—leprosy	0.00107	0.00818	CcSEcCtD
Meloxicam—Tinnitus—Dapsone—leprosy	0.00104	0.00793	CcSEcCtD
Meloxicam—Oesophagitis—Thalidomide—leprosy	0.00104	0.00792	CcSEcCtD
Meloxicam—Rash maculo-papular—Thalidomide—leprosy	0.00103	0.00788	CcSEcCtD
Meloxicam—Lightheadedness—Thalidomide—leprosy	0.00102	0.00775	CcSEcCtD
Meloxicam—Erythema—Dapsone—leprosy	0.000969	0.0074	CcSEcCtD
Meloxicam—Photosensitivity—Thalidomide—leprosy	0.000938	0.00716	CcSEcCtD
Meloxicam—Vascular purpura—Thalidomide—leprosy	0.000921	0.00703	CcSEcCtD
Meloxicam—Vision blurred—Dapsone—leprosy	0.000913	0.00698	CcSEcCtD
Meloxicam—Cardiac failure congestive—Thalidomide—leprosy	0.000909	0.00694	CcSEcCtD
Meloxicam—Renal failure acute—Thalidomide—leprosy	0.000892	0.00681	CcSEcCtD
Meloxicam—Increased appetite—Thalidomide—leprosy	0.000877	0.0067	CcSEcCtD
Meloxicam—Dermatitis exfoliative—Thalidomide—leprosy	0.000873	0.00667	CcSEcCtD
Meloxicam—Vertigo—Dapsone—leprosy	0.000871	0.00665	CcSEcCtD
Meloxicam—Visual disturbance—Thalidomide—leprosy	0.000869	0.00664	CcSEcCtD
Meloxicam—Dermatitis bullous—Thalidomide—leprosy	0.000862	0.00658	CcSEcCtD
Meloxicam—Purpura—Thalidomide—leprosy	0.000855	0.00653	CcSEcCtD
Meloxicam—Arthritis—Thalidomide—leprosy	0.000848	0.00647	CcSEcCtD
Meloxicam—Cough—Dapsone—leprosy	0.000846	0.00646	CcSEcCtD
Meloxicam—Cardiac failure—Thalidomide—leprosy	0.000844	0.00645	CcSEcCtD
Meloxicam—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000824	0.00629	CcSEcCtD
Meloxicam—Pain in extremity—Thalidomide—leprosy	0.000824	0.00629	CcSEcCtD
Meloxicam—Affect lability—Thalidomide—leprosy	0.000811	0.00619	CcSEcCtD
Meloxicam—Face oedema—Thalidomide—leprosy	0.000795	0.00607	CcSEcCtD
Meloxicam—Mood swings—Thalidomide—leprosy	0.000781	0.00596	CcSEcCtD
Meloxicam—Tachycardia—Dapsone—leprosy	0.000772	0.0059	CcSEcCtD
Meloxicam—Blood creatinine increased—Thalidomide—leprosy	0.000772	0.00589	CcSEcCtD
Meloxicam—Dehydration—Thalidomide—leprosy	0.000766	0.00585	CcSEcCtD
Meloxicam—Liver function test abnormal—Thalidomide—leprosy	0.000761	0.00581	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000742	0.00567	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000742	0.00567	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Thalidomide—leprosy	0.000727	0.00555	CcSEcCtD
Meloxicam—Insomnia—Dapsone—leprosy	0.000715	0.00546	CcSEcCtD
Meloxicam—Influenza—Thalidomide—leprosy	0.000712	0.00544	CcSEcCtD
Meloxicam—Bronchospasm—Thalidomide—leprosy	0.0007	0.00535	CcSEcCtD
Meloxicam—Pancreatitis—Thalidomide—leprosy	0.000698	0.00533	CcSEcCtD
Meloxicam—Angina pectoris—Thalidomide—leprosy	0.000694	0.0053	CcSEcCtD
Meloxicam—Bronchitis—Thalidomide—leprosy	0.000685	0.00523	CcSEcCtD
Meloxicam—Pancytopenia—Thalidomide—leprosy	0.000676	0.00516	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Thalidomide—leprosy	0.000662	0.00505	CcSEcCtD
Meloxicam—Pollakiuria—Thalidomide—leprosy	0.000658	0.00502	CcSEcCtD
Meloxicam—Photosensitivity reaction—Thalidomide—leprosy	0.00065	0.00496	CcSEcCtD
Meloxicam—Weight increased—Thalidomide—leprosy	0.000648	0.00495	CcSEcCtD
Meloxicam—Gastrointestinal pain—Dapsone—leprosy	0.000647	0.00494	CcSEcCtD
Meloxicam—Weight decreased—Thalidomide—leprosy	0.000644	0.00492	CcSEcCtD
Meloxicam—Infestation NOS—Thalidomide—leprosy	0.000635	0.00485	CcSEcCtD
Meloxicam—Infestation—Thalidomide—leprosy	0.000635	0.00485	CcSEcCtD
Meloxicam—Drowsiness—Thalidomide—leprosy	0.000635	0.00485	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00063	0.00481	CcSEcCtD
Meloxicam—Acute coronary syndrome—Thalidomide—leprosy	0.000626	0.00478	CcSEcCtD
Meloxicam—Body temperature increased—Dapsone—leprosy	0.000625	0.00478	CcSEcCtD
Meloxicam—Abdominal pain—Dapsone—leprosy	0.000625	0.00478	CcSEcCtD
Meloxicam—Renal failure—Thalidomide—leprosy	0.000624	0.00477	CcSEcCtD
Meloxicam—Myocardial infarction—Thalidomide—leprosy	0.000622	0.00475	CcSEcCtD
Meloxicam—Stomatitis—Thalidomide—leprosy	0.000619	0.00473	CcSEcCtD
Meloxicam—Conjunctivitis—Thalidomide—leprosy	0.000617	0.00471	CcSEcCtD
Meloxicam—Sweating—Thalidomide—leprosy	0.000609	0.00465	CcSEcCtD
Meloxicam—Haematuria—Thalidomide—leprosy	0.000605	0.00462	CcSEcCtD
Meloxicam—Sinusitis—Thalidomide—leprosy	0.000596	0.00455	CcSEcCtD
Meloxicam—Agranulocytosis—Thalidomide—leprosy	0.000593	0.00452	CcSEcCtD
Meloxicam—Rhinitis—Thalidomide—leprosy	0.000571	0.00436	CcSEcCtD
Meloxicam—Hepatitis—Thalidomide—leprosy	0.00057	0.00435	CcSEcCtD
Meloxicam—Pharyngitis—Thalidomide—leprosy	0.000566	0.00432	CcSEcCtD
Meloxicam—Urinary tract disorder—Thalidomide—leprosy	0.000563	0.0043	CcSEcCtD
Meloxicam—Oedema peripheral—Thalidomide—leprosy	0.000562	0.00429	CcSEcCtD
Meloxicam—Urethral disorder—Thalidomide—leprosy	0.000559	0.00427	CcSEcCtD
Meloxicam—Visual impairment—Thalidomide—leprosy	0.000549	0.00419	CcSEcCtD
Meloxicam—Erythema multiforme—Thalidomide—leprosy	0.000539	0.00412	CcSEcCtD
Meloxicam—Eye disorder—Thalidomide—leprosy	0.000533	0.00407	CcSEcCtD
Meloxicam—Tinnitus—Thalidomide—leprosy	0.000531	0.00406	CcSEcCtD
Meloxicam—Cardiac disorder—Thalidomide—leprosy	0.000529	0.00404	CcSEcCtD
Meloxicam—Angiopathy—Thalidomide—leprosy	0.000517	0.00395	CcSEcCtD
Meloxicam—Immune system disorder—Thalidomide—leprosy	0.000515	0.00393	CcSEcCtD
Meloxicam—Mediastinal disorder—Thalidomide—leprosy	0.000514	0.00392	CcSEcCtD
Meloxicam—Arrhythmia—Thalidomide—leprosy	0.000509	0.00389	CcSEcCtD
Meloxicam—Alopecia—Thalidomide—leprosy	0.000504	0.00385	CcSEcCtD
Meloxicam—Vomiting—Dapsone—leprosy	0.000503	0.00384	CcSEcCtD
Meloxicam—Mental disorder—Thalidomide—leprosy	0.000499	0.00381	CcSEcCtD
Meloxicam—Malnutrition—Thalidomide—leprosy	0.000496	0.00379	CcSEcCtD
Meloxicam—Headache—Dapsone—leprosy	0.000496	0.00378	CcSEcCtD
Meloxicam—Flatulence—Thalidomide—leprosy	0.000489	0.00373	CcSEcCtD
Meloxicam—Tension—Thalidomide—leprosy	0.000487	0.00372	CcSEcCtD
Meloxicam—Dysgeusia—Thalidomide—leprosy	0.000486	0.00371	CcSEcCtD
Meloxicam—Nervousness—Thalidomide—leprosy	0.000482	0.00368	CcSEcCtD
Meloxicam—Back pain—Thalidomide—leprosy	0.00048	0.00366	CcSEcCtD
Meloxicam—Muscle spasms—Thalidomide—leprosy	0.000477	0.00364	CcSEcCtD
Meloxicam—Nausea—Dapsone—leprosy	0.00047	0.00359	CcSEcCtD
Meloxicam—Vision blurred—Thalidomide—leprosy	0.000468	0.00357	CcSEcCtD
Meloxicam—Tremor—Thalidomide—leprosy	0.000465	0.00355	CcSEcCtD
Meloxicam—PTGS2—hindlimb—leprosy	0.000461	0.123	CbGeAlD
Meloxicam—Ill-defined disorder—Thalidomide—leprosy	0.00046	0.00352	CcSEcCtD
Meloxicam—Anaemia—Thalidomide—leprosy	0.000459	0.0035	CcSEcCtD
Meloxicam—Angioedema—Thalidomide—leprosy	0.000453	0.00346	CcSEcCtD
Meloxicam—Malaise—Thalidomide—leprosy	0.000447	0.00342	CcSEcCtD
Meloxicam—Vertigo—Thalidomide—leprosy	0.000446	0.0034	CcSEcCtD
Meloxicam—Syncope—Thalidomide—leprosy	0.000445	0.0034	CcSEcCtD
Meloxicam—Leukopenia—Thalidomide—leprosy	0.000444	0.00339	CcSEcCtD
Meloxicam—Palpitations—Thalidomide—leprosy	0.000438	0.00335	CcSEcCtD
Meloxicam—Loss of consciousness—Thalidomide—leprosy	0.000436	0.00333	CcSEcCtD
Meloxicam—Cough—Thalidomide—leprosy	0.000433	0.00331	CcSEcCtD
Meloxicam—Convulsion—Thalidomide—leprosy	0.00043	0.00328	CcSEcCtD
Meloxicam—Hypertension—Thalidomide—leprosy	0.000428	0.00327	CcSEcCtD
Meloxicam—Myalgia—Thalidomide—leprosy	0.000422	0.00323	CcSEcCtD
Meloxicam—Arthralgia—Thalidomide—leprosy	0.000422	0.00323	CcSEcCtD
Meloxicam—Anxiety—Thalidomide—leprosy	0.000421	0.00321	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00042	0.0032	CcSEcCtD
Meloxicam—Discomfort—Thalidomide—leprosy	0.000417	0.00319	CcSEcCtD
Meloxicam—Dry mouth—Thalidomide—leprosy	0.000413	0.00315	CcSEcCtD
Meloxicam—Confusional state—Thalidomide—leprosy	0.000408	0.00312	CcSEcCtD
Meloxicam—Oedema—Thalidomide—leprosy	0.000405	0.00309	CcSEcCtD
Meloxicam—Infection—Thalidomide—leprosy	0.000402	0.00307	CcSEcCtD
Meloxicam—Shock—Thalidomide—leprosy	0.000398	0.00304	CcSEcCtD
Meloxicam—Nervous system disorder—Thalidomide—leprosy	0.000397	0.00303	CcSEcCtD
Meloxicam—Thrombocytopenia—Thalidomide—leprosy	0.000397	0.00303	CcSEcCtD
Meloxicam—PTGS2—appendage—leprosy	0.000396	0.105	CbGeAlD
Meloxicam—Tachycardia—Thalidomide—leprosy	0.000395	0.00302	CcSEcCtD
Meloxicam—Skin disorder—Thalidomide—leprosy	0.000393	0.003	CcSEcCtD
Meloxicam—Hyperhidrosis—Thalidomide—leprosy	0.000391	0.00299	CcSEcCtD
Meloxicam—Hypotension—Thalidomide—leprosy	0.000378	0.00289	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Thalidomide—leprosy	0.000369	0.00282	CcSEcCtD
Meloxicam—Insomnia—Thalidomide—leprosy	0.000366	0.0028	CcSEcCtD
Meloxicam—Paraesthesia—Thalidomide—leprosy	0.000364	0.00278	CcSEcCtD
Meloxicam—Dyspnoea—Thalidomide—leprosy	0.000361	0.00276	CcSEcCtD
Meloxicam—Somnolence—Thalidomide—leprosy	0.00036	0.00275	CcSEcCtD
Meloxicam—Dyspepsia—Thalidomide—leprosy	0.000356	0.00272	CcSEcCtD
Meloxicam—Decreased appetite—Thalidomide—leprosy	0.000352	0.00269	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Thalidomide—leprosy	0.00035	0.00267	CcSEcCtD
Meloxicam—Fatigue—Thalidomide—leprosy	0.000349	0.00267	CcSEcCtD
Meloxicam—Pain—Thalidomide—leprosy	0.000346	0.00264	CcSEcCtD
Meloxicam—Constipation—Thalidomide—leprosy	0.000346	0.00264	CcSEcCtD
Meloxicam—Feeling abnormal—Thalidomide—leprosy	0.000334	0.00255	CcSEcCtD
Meloxicam—Gastrointestinal pain—Thalidomide—leprosy	0.000331	0.00253	CcSEcCtD
Meloxicam—PTGS2—skin epidermis—leprosy	0.000329	0.0875	CbGeAlD
Meloxicam—Urticaria—Thalidomide—leprosy	0.000322	0.00246	CcSEcCtD
Meloxicam—Abdominal pain—Thalidomide—leprosy	0.00032	0.00244	CcSEcCtD
Meloxicam—Body temperature increased—Thalidomide—leprosy	0.00032	0.00244	CcSEcCtD
Meloxicam—Hypersensitivity—Thalidomide—leprosy	0.000298	0.00228	CcSEcCtD
Meloxicam—PGD—eye—leprosy	0.000293	0.0778	CbGeAlD
Meloxicam—Asthenia—Thalidomide—leprosy	0.000291	0.00222	CcSEcCtD
Meloxicam—Pruritus—Thalidomide—leprosy	0.000287	0.00219	CcSEcCtD
Meloxicam—Diarrhoea—Thalidomide—leprosy	0.000277	0.00212	CcSEcCtD
Meloxicam—Dizziness—Thalidomide—leprosy	0.000268	0.00204	CcSEcCtD
Meloxicam—Vomiting—Thalidomide—leprosy	0.000257	0.00197	CcSEcCtD
Meloxicam—Rash—Thalidomide—leprosy	0.000255	0.00195	CcSEcCtD
Meloxicam—Dermatitis—Thalidomide—leprosy	0.000255	0.00195	CcSEcCtD
Meloxicam—PGD—skin of body—leprosy	0.000255	0.0677	CbGeAlD
Meloxicam—Headache—Thalidomide—leprosy	0.000254	0.00194	CcSEcCtD
Meloxicam—Nausea—Thalidomide—leprosy	0.000241	0.00184	CcSEcCtD
Meloxicam—PTGS1—blood vessel—leprosy	0.000231	0.0612	CbGeAlD
Meloxicam—PTGS2—blood vessel—leprosy	0.00022	0.0585	CbGeAlD
Meloxicam—PGD—tendon—leprosy	0.000194	0.0515	CbGeAlD
Meloxicam—PGD—testis—leprosy	0.000161	0.0427	CbGeAlD
Meloxicam—PGD—nervous system—leprosy	0.000158	0.0419	CbGeAlD
Meloxicam—ABCC4—tendon—leprosy	0.000138	0.0367	CbGeAlD
Meloxicam—ABCC4—testis—leprosy	0.000114	0.0304	CbGeAlD
Meloxicam—ABCC4—nervous system—leprosy	0.000112	0.0298	CbGeAlD
Meloxicam—PTGS1—skin of body—leprosy	0.000107	0.0283	CbGeAlD
Meloxicam—PTGS2—skin of body—leprosy	0.000102	0.0271	CbGeAlD
Meloxicam—CYP2C8—testis—leprosy	8.3e-05	0.022	CbGeAlD
Meloxicam—PTGS1—tendon—leprosy	8.12e-05	0.0216	CbGeAlD
Meloxicam—PTGS2—tendon—leprosy	7.77e-05	0.0206	CbGeAlD
Meloxicam—PTGS1—testis—leprosy	6.73e-05	0.0179	CbGeAlD
Meloxicam—PTGS1—nervous system—leprosy	6.6e-05	0.0175	CbGeAlD
Meloxicam—PTGS2—nervous system—leprosy	6.31e-05	0.0168	CbGeAlD
Meloxicam—CYP3A4—nervous system—leprosy	5.51e-05	0.0146	CbGeAlD
